Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06521567
Title A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DNK | DEU | CZE | BRA | ARG

Facility Status City State Zip Country Details
GSK Investigational Site West Hollywood California 90048 United States Details
GSK Investigational Site Iowa City Iowa 52242-1009 United States Details
GSK Investigational Site Boston Massachusetts 02115 United States Details
GSK Investigational Site Hackensack New Jersey 07601 United States Details
GSK Investigational Site Cincinnati Ohio 45229 United States Details
GSK Investigational Site Providence Rhode Island 02903 United States Details
GSK Investigational Site Madison Wisconsin 53792 United States Details
GSK Investigational Site Buenos Aires C1181ACH Argentina Details
GSK Investigational Site Buenos Aires C1428AQK Argentina Details
GSK Investigational Site Recife Pernambuco 50070-550 Brazil Details
GSK Investigational Site Jaú Sao Paulo 17210-120 Brazil Details
GSK Investigational Site São Paulo Sao Paulo 08270-070 Brazil Details
GSK Investigational Site Barretos São Paulo 14784-400 Brazil Details
GSK Investigational Site Porto Alegre 90035-003 Brazil Details
GSK Investigational Site Rio de Janeiro 20230-130 Brazil Details
GSK Investigational Site Brno 61300 Czechia Details
GSK Investigational Site Praha 5 15006 Czechia Details
GSK Investigational Site Copenhagen 2100 Denmark Details
GSK Investigational Site Lyon cedex 08 69373 France Details
GSK Investigational Site Marseille 13005 France Details
GSK Investigational Site Paris Cedex 05 75248 France Details
GSK Investigational Site Strasbourg 67098 France Details
GSK Investigational Site Villejuif 94805 France Details
GSK Investigational Site Wuerzburg Bayern 97080 Germany Details
GSK Investigational Site Berlin 13353 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Bologna Emilia-Romagna 40138 Italy Details
GSK Investigational Site Roma Lazio 00165 Italy Details
GSK Investigational Site Torino Piemonte 10126 Italy Details
GSK Investigational Site Napoli 80123 Italy Details
GSK Investigational Site Goyang-si Gyeonggi-do 10408 Korea, Republic of Details
GSK Investigational Site Seoul 03080 Korea, Republic of Details
GSK Investigational Site Seoul 03722 Korea, Republic of Details
GSK Investigational Site Seoul 06351 Korea, Republic of Details
GSK Investigational Site Seoul 138-736 Korea, Republic of Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28009 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field